Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (CMT2A) Linked to Mitofusin 2

NCT04881201 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04881201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04881201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolomic Exploration of Dysregulated Lipid Metabolism in MFN2-related CMT2A (CMT2A) Linked to Mitofusin 2
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2022
Completion date
June 10, 2024
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

charcot-marie-tooth disease type 2a